Cambridge, MA, United States of America

Karthik Iyer

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 16.1

ph-index = 3

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Karthik Iyer: Innovator in Pharmaceutical Formulations

Introduction

Karthik Iyer is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of pharmaceutical formulations. With a total of 10 patents to his name, Iyer has made remarkable strides in developing innovative solutions for various medical conditions.

Latest Patents

One of Iyer's latest patents focuses on sGC stimulators. The present disclosure relates to stimulators of soluble guanylate cyclase (sGC), pharmaceutical formulations comprising them, and their uses for treating various diseases. An increase in the concentration of nitric oxide (NO) and/or cyclic Guanosine Monophosphate (cGMP) may be desirable in these treatments. Various compounds are disclosed, including those of Formula I. Compounds of Formulae I' and I are described as useful sGC stimulators, particularly NO-independent, heme-dependent stimulators. These compounds are also beneficial for treating, preventing, or managing various disorders.

Career Highlights

Throughout his career, Karthik Iyer has worked with notable companies such as Cyclerion Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc. His work has significantly impacted the pharmaceutical industry, particularly in the development of innovative treatments.

Collaborations

Iyer has collaborated with esteemed colleagues, including Takashi Nakai and Rajesh R Iyengar, contributing to the advancement of research and development in his field.

Conclusion

Karthik Iyer's innovative work in pharmaceutical formulations and his numerous patents highlight his dedication to improving medical treatments. His contributions continue to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…